Back
Global X SuperDividend REIT ETF Vs. United Therapeutics Corp. Industry Stock Comparison
Sell
32
SRET
Global X SuperDividend REIT ETF
Last Price:
$21.87
Seasonality Move:
-1.6%
Buy
55
UTHR
United Therapeutics Corp.
Last Price:
$507.08
Seasonality Move:
3.94%
Sell
32
Global X SuperDividend REIT ETF (SRET)
is a Sell
Is Global X SuperDividend REIT ETF a Buy, Sell or Hold?
-
The current Global X SuperDividend REIT ETF [SRET] share price is $21.89. The Score for SRET is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
-
SRET is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
55
United Therapeutics Corp. (UTHR)
is a Buy
Is United Therapeutics Corp. a Buy, Sell or Hold?
-
The current United Therapeutics Corp. [UTHR] share price is $507.16. The Score for UTHR is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
-
UTHR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SRET Stock Price Chart
What is Global X SuperDividend REIT ETF's stock price today?
-
The Global X SuperDividend REIT ETF share price today is $21.89Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRET is experiencing buying pressure, which is a positive indicator for future bullish movement.
UTHR Stock Price Chart
What is United Therapeutics Corp.'s stock price today?
-
The United Therapeutics Corp. share price today is $507.16Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UTHR is experiencing selling pressure, which indicates risk of future bearish movement.
SRET Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.75 | Buy |
| Relative Strength Index (14 RSI): | 56.09 | Buy |
| Chaikin Money Flow: | 28926 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (21.57 - 21.93) | Buy |
| Bollinger Bands (100): | (21.43 - 21.89) | Buy |
UTHR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 139.54 | Buy |
| Relative Strength Index (14 RSI): | 61.81 | Buy |
| Chaikin Money Flow: | -106696 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (477.96 - 506.04) | Buy |
| Bollinger Bands (100): | (361.22 - 487.78) | Buy |
SRET Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.79 | Buy |
| 20-day SMA: | 21.77 | Buy |
| 50-day SMA: | 21.73 | Buy |
| 200-day SMA: | 21.21 | Buy |
| 8-day EMA: | 17.01 | Buy |
| 20-day EMA: | 9.86 | Buy |
| 50-day EMA: | 4.66 | Buy |
| 200-day EMA: | 1.27 | Buy |
UTHR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 510.14 | Sell |
| 20-day SMA: | 494.95 | Buy |
| 50-day SMA: | 468.66 | Buy |
| 200-day SMA: | 362.18 | Buy |
| 8-day EMA: | 423.25 | Buy |
| 20-day EMA: | 257.65 | Buy |
| 50-day EMA: | 124.95 | Buy |
| 200-day EMA: | 34.59 | Buy |
Global X SuperDividend REIT ETF Earnings Growth & SRET Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
United Therapeutics Corp. Earnings Growth & UTHR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.90 per share, and an increase next year of $1.85 per share.
Global X SuperDividend REIT ETF Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
United Therapeutics Corp. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||